Paradoxical Pulmonary Event Under Tocilizumab Treatment for Systemic Sclerosis-Associated Usual Interstitial Pneumonia

Oliveira, ALRuano, CRiso, NCepeda Ribeiro, JMoraes-Fontes, MF2023-05-222023-05-222020Ann Rheum Dis . 2020 Feb;79(2):e22.http://hdl.handle.net/10400.17/4525engHCC DAUTOIMHSM IMAAntibodies, Monoclonal, HumanizedHumansLungIdiopathic Pulmonary Fibrosis*Scleroderma, Systemic*Paradoxical Pulmonary Event Under Tocilizumab Treatment for Systemic Sclerosis-Associated Usual Interstitial Pneumoniajournal article10.1136/annrheumdis-2018-214747